{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:16:19Z","timestamp":1749096979707,"version":"3.41.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Early pneumonia is an independent risk factor for 1-y mortality after lung transplantation (LTx). <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic> is the most common isolate in early pneumonia and is also associated with an increased risk of chronic lung allograft dysfunction. The aim of our study was to evaluate the efficacy of secondary prophylaxis with inhaled colistin (IC) in preventing the recurrence of <jats:italic toggle=\"yes\">P aeruginosa<\/jats:italic> or extended-spectrum \u03b2-lactamase-producing <jats:italic toggle=\"yes\">Enterobacterales<\/jats:italic> (ESBL-PE) pneumonia in the postoperative period in the intensive care unit after LTx.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We conducted a before-and-after retrospective cohort study by including all patients who underwent LTx between January 2015 and December 2020 in our center. Secondary prophylaxis with IC was instituted in January 2018 (observation period from January 2015 to December 2017, intervention period from January 2018 to December 2020).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>A total of 271 lung transplants were included (125 in the observation period and 146 in the intervention period). The patients were predominately male (64.2%) with a median age of 57 y and received double LTx (67.9%) for chronic obstructive pulmonary disease\/emphysema (36.2%) or interstitial lung disease (48.3%). The proportion of patients who experienced at least 1 recurrence of <jats:italic toggle=\"yes\">P aeruginosa<\/jats:italic> or ESBL-PE pneumonia was significantly lower in the intervention period than in the observation period (0.7% versus 7.2%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our study suggests a potential benefit of secondary prophylaxis with IC to prevent the recurrence of <jats:italic toggle=\"yes\">P aeruginosa<\/jats:italic> or ESBL-PE pneumonia in the intensive care unit after LTx.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004187","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T19:00:22Z","timestamp":1654714822000},"page":"2232-2240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Secondary Prophylaxis With Inhaled Colistin to Prevent Recurrence of Pseudomonas aeruginosa and Extended-spectrum \u03b2-lactamase-producing Enterobacterales Pneumonia in ICU After Lung Transplantation: A Before-and-after Retrospective Cohort Analysis"],"prefix":"10.1097","volume":"106","author":[{"given":"Alexy","family":"Tran-Dinh","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."},{"name":"INSERM UMR 1148 LVTS, Universit\u00e9 de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Slassi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"De Tymowski","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maksud","family":"Assadi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."},{"name":"R\u00e9union Island University, INSERM U1188 Diabetes Atherothrombosis R\u00e9union Indian OCean (D\u00e9TROI), CYROI Plateform, Saint-Denis de la R\u00e9union, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Zappella","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Lortat Jacob","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Jean-Baptiste","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enora","family":"Atchade","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, D\u00e9partement d\u2019Anesth\u00e9sie-R\u00e9animation, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Castier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire, Paris, France."},{"name":"INSERM UMR 1152 PHERE, Universit\u00e9 de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Mal","sequence":"additional","affiliation":[{"name":"INSERM UMR 1152 PHERE, Universit\u00e9 de Paris, Paris, France."},{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, Pneumologie B et Transplantation Pulmonaire, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Mordant","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire, Paris, France."},{"name":"INSERM UMR 1152 PHERE, Universit\u00e9 de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Armand-Lef\u00e8vre","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, Service de bact\u00e9riologie, Paris, France."},{"name":"INSERM UMR 1137 IAME, Universit\u00e9 de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Messika","sequence":"additional","affiliation":[{"name":"INSERM UMR 1152 PHERE, Universit\u00e9 de Paris, Paris, France."},{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, Pneumologie B et Transplantation Pulmonaire, Paris, France."},{"name":"Paris Transplant Group."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Grall","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, AP-HP, H\u00f4pital Bichat Claude Bernard, Service de bact\u00e9riologie, Paris, France."},{"name":"INSERM UMR 1137 IAME, Universit\u00e9 de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Montravers","sequence":"additional","affiliation":[{"name":"INSERM UMR 1148 LVTS, Universit\u00e9 de Paris, Paris, France."},{"name":"INSERM UMR 1152 PHERE, Universit\u00e9 de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.healun.2004.04.012","article-title":"Does lung transplantation improve health-related quality of life? The University of Florida experience.","volume":"24","author":"Rodrigue","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.healun.2005.08.008","article-title":"Health-related quality-of-life determinants in lung transplantation.","volume":"25","author":"Vasiliadis","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match.","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant.","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1600-6143.2007.01882.x","article-title":"Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study.","volume":"7","author":"Aguilar-Guisado","year":"2007","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"2001720","DOI":"10.1183\/13993003.01720-2020","article-title":"Successful Pseudomonas aeruginosa eradication improves outcomes after lung transplantation: a retrospective cohort analysis.","volume":"56","author":"De Muynck","year":"2020","journal-title":"Eur Respir J"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/342570","article-title":"Colistin: an antimicrobial for the 21st century?","volume":"35","author":"Stein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections.","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: an update on the antibiotic of the 21st century.","volume":"10","author":"Biswas","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann Intensive Care"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2017.05.016","article-title":"Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.","volume":"51","author":"Vardakas","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1183\/13993003.02235-2014","article-title":"Nebulised colistin for ventilator-associated pneumonia prevention.","volume":"46","author":"Karvouniaris","year":"2015","journal-title":"Eur Respir J"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1479973119872513","DOI":"10.1177\/1479973119872513","article-title":"Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis.","volume":"16","author":"Blanco-Aparicio","year":"2019","journal-title":"Chron Respir Dis"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.","volume":"189","author":"Haworth","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/CE.S64980","article-title":"Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.","volume":"9","author":"Koerner-Rettberg","year":"2014","journal-title":"Core Evid"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1183\/09031936.00201012","article-title":"Inhaled colistin following lung transplantation in colonised cystic fibrosis patients.","volume":"42","author":"Suhling","year":"2013","journal-title":"Eur Respir J"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients.","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT).","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciw504","article-title":"Executive summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.healun.2014.09.025","article-title":"Post-operative kinetics of procalcitonin after lung transplantation.","volume":"34","author":"Desmard","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/2319-4170.132879","article-title":"Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin.","volume":"37","author":"Wang","year":"2014","journal-title":"Biomed J"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"e12278","DOI":"10.1097\/MD.0000000000012278","article-title":"Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: is there any benefit of adding tigecycline to aerosolized colistimethate sodium?","volume":"97","author":"Jean","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the era of antibiotic resistance: an extended review (2000-2019).","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/bip.22095","article-title":"Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems.","volume":"98","author":"Domingues","year":"2012","journal-title":"Biopolymers"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","article-title":"Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.","volume":"36","author":"Lu","year":"2010","journal-title":"Intensive Care Med"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/JB.00720-06","article-title":"Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms.","volume":"189","author":"Haagensen","year":"2007","journal-title":"J Bacteriol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/iai.28.2.546-556.1980","article-title":"Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.","volume":"28","author":"Lam","year":"1980","journal-title":"Infect Immun"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/656788","article-title":"Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.","volume":"202","author":"Herrmann","year":"2010","journal-title":"J Infect Dis"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2958.2008.06152.x","article-title":"Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.","volume":"68","author":"Pamp","year":"2008","journal-title":"Mol Microbiol"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/432583","article-title":"Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.","volume":"41","author":"Kwa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1471-2334-13-380","article-title":"Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study.","volume":"13","author":"Sorl\u00ed","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.02587-12","article-title":"Polymyxin B induces apoptosis in kidney proximal tubular cells.","volume":"57","author":"Azad","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/jac\/dky044","article-title":"Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria.","volume":"73","author":"Bihan","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01704698","article-title":"Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study.","volume":"20","author":"Rouby","year":"1994","journal-title":"Intensive Care Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:03:58Z","timestamp":1749063838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004187","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}